This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Charlotte, NC-based Albemarle Corporation is a premier specialty chemicals company with leading positions in attractive end markets globally. It is a leading producer of highly-engineered specialty chemicals geared to meet customer requirements across a bevy of end markets including petroleum refining, consumer electronics, energy storage, construction and automotive.
Albemarle (ALB) to Post Q1 Earnings: What's in the Offing?
by Zacks Equity Research
The impact of lower prices is expected to reflect in Albemarle's (ALB) Lithium segment margins in Q1.
Earnings Preview: Albemarle (ALB) Q1 Earnings Expected to Decline
by Zacks Equity Research
Albemarle (ALB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Albemarle (ALB) Gains on Lithium Expansions Amid Pricing Woes
by Zacks Equity Research
Albemarle (ALB) is poised to benefit from actions to boost its global lithium derivative capacity and strong long-term demand for lithium.
Coronavirus Casts a Pall Over Diversified Chemical Industry
by Anindya Barman
Soft demand and raw material cost pressure due to coronavirus pose as headwinds to diversified chemicals companies.
Albemarle (ALB) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Albemarle (ALB) closed the most recent trading day at $60.46, moving +0.73% from the previous trading session.
Albemarle (ALB) Down 34.3% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Albemarle (ALB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why You Should Keep Albemarle (ALB) Stock in Your Portfolio
by Zacks Equity Research
Let's find out why Albemarle (ALB) stock is worth retaining at the moment.
Albemarle (ALB) Announces Hike of 5% in Quarterly Dividend
by Zacks Equity Research
Albemarle (ALB) hikes its dividend for the 26th consecutive year.
Coronavirus Casts a Pall Over Chemical Industry: Here's How
by Anindya Barman
Chemical makers brace for short-term demand shocks and raw material supply disruptions as a result of the deadly outbreak.
Albemarle (ALB) Surges: Stock Moves 5.6% Higher
by Zacks Equity Research
Albemarle (ALB) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Albemarle (ALB) Q4 Earnings & Sales Miss, View Disappoints
by Zacks Equity Research
Higher volumes in the Lithium unit contributed to the rise in Albemarle's (ALB) sales in Q4. The company sees lower results in 2020.
Albemarle (ALB) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Our proven model does not predict an earnings beat for Albemarle (ALB) in Q4.
S&P 500 Up 1000 Points in a Month: 10 Stocks Boosted the ETF
by Sanghamitra Saha
The S&P 500 touched the 3,300 mark on Jan 16, having added 1000 points in less than a month. Which stocks led to the ETF rally.
Albemarle Set to Gain on Lithium Demand Amid Pricing Woes
by Zacks Equity Research
Albemarle (ALB) benefits from strong demand for lithium in battery-grade applications and its expansion initiatives.
Here's Why You Should Hold Onto Albemarle (ALB) Stock for Now
by Zacks Equity Research
Albemarle (ALB) gains from strong demand for lithium and its expansion actions amid a challenging pricing environment.
Why Is Albemarle (ALB) Down 10.8% Since Last Earnings Report?
by Zacks Equity Research
Albemarle (ALB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
New Strong Sell Stocks for November 12th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Albemarle (ALB) Tops Q3 Earnings Estimates, Revenues Lag
by Zacks Equity Research
Albemarle (ALB) benefited from higher sales and earnings across its segments in Q3.
Albemarle (ALB) Beats Q3 Earnings Estimates
by Zacks Equity Research
Albemarle (ALB) delivered earnings and revenue surprises of 2.68% and -2.13%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for November 6th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Albemarle (ALB) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Our proven model does not conclusively predict that Albemarle (ALB) is likely to beat the Zacks Consensus Estimate this quarter.
4 Stocks in Focus on Electric Vehicle Revolution
by Manaswita Ghosh Dutta
As more automakers come up with affordable electric-powered cars, mass-adoption of these could be sooner than expected. Here's how to make the most of it.
Albemarle (ALB) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Albemarle (ALB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are You Looking for a High-Growth Dividend Stock? Albemarle (ALB) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Albemarle (ALB) have what it takes? Let's find out.
This is Why Albemarle (ALB) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Albemarle (ALB) have what it takes? Let's find out.